Irritable Bowel Syndrome  >>  Xifaxan (rifaximin)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Xifaxan (rifaximin) / Alfa Wassermann, Bausch Health
NCT00259155: Rifaximin for the Treatment of Irritable Bowel Syndrome

Completed
2
92
US
Rifaximin
Cedars-Sinai Medical Center, University of Chicago, Bausch Health Americas, Inc.
Irritable Bowel Syndrome
01/07
01/07

Download Options